Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mitoxantrone - an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis.
Firategrast: natalizumab in a pill?
Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Clinically isolated syndrome - Rethinking the diagnosis.
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
The role of natural killer cells in multiple sclerosis and their therapeutic implications.
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity.
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
Delayed visual evoked response in optic neuritis.

Pages